Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Hua Medicine logo — company profile

Hua Medicine

Founded 2010 56 employees Series E Total: $242.40M Biotechnology, Health Care +2

General Information

Company Name Hua Medicine
Founded Year 2010
Employees 56
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage Series E
Social

BounceWatch is an independent company data service, not affiliated with Hua Medicine. To contact Hua Medicine, visit huamedicine.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Hua Medicine compare?

A PDF of Hua Medicine and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Hua Medicine soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Hua Medicine

is a prominent clinical-stage, innovative drug development company in China, specializing in novel therapies for diabetes and CNS disorders. Founded in 2010, the company has gained recognition in the Biotechnology, Health Care, Life Sciences, and Pharmaceutical industries. Recently, Series E investment was secured on 29 March 2018. Notably, this round witnessed participation from unknown investors. To maintain global standards, has implemented an internal research quality supervision system Q (QC/QA) based on the advanced open innovation model VIC (VC + IP + CRO). This signifies the company's commitment to ensuring high-quality and innovative solutions in the medical field.

Business keywords: Drug development, Clinical-stage company, Diabetes treatment, CNS disorder treatment, Pharmaceutical industry, Innovation, Research and development, VC funding, International standards, Open innovation, Intellectual property, Quality control, Quality assurance, Investment

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series E Undisclosed -
29 Mar 2018
Series D $117.40M 10
Eight Roads Ventures F-Prime Capital GIC
Eight Roads Ventures, F-Prime Capital +8
27 Mar 2018
Series C $50.00M 10
Arch Venture Partners Eight Roads Ventures F-Prime Capital
Arch Venture Partners, Eight Roads Ventures +8
21 Apr 2016
Series B $25.00M 8
Arch Venture Partners Venrock WuXi Healthcare Ventures
Arch Venture Partners, Venrock +6
08 Jan 2015
Series A $50.00M 6
Arch Venture Partners Eight Roads Ventures F-Prime Capital
Arch Venture Partners, Eight Roads Ventures +4
20 Sep 2011
Venture Round Undisclosed 1
Eight Roads Ventures
Eight Roads Ventures
04 Aug 2010

Hua Medicine Alternatives & Competitors

View All Alternatives
Hua Medicine vs
Genprex, Inc.
Genprex, Inc. United States

Genprex is a gene therapy company focused on developing life-changing technologies for patients with...

Post-IPO Equity
24 employees
Biopharma, Biotechnology
Hua Medicine vs
Creative BioTherapeutics LLC
Creative BioTherapeutics LLC United States

An emerging biotech discovering & developing novel therapies for cancer and viruses where other opti...

6 employees
Biotechnology, Health Care
Hua Medicine vs
BeBetter Med
BeBetter Med China

Clinical-stage drug discovery and development of advanced novel medicines for cancer and other sever...

Private Equity
5 employees
Health Care, Pharmaceutical
View all alternatives

FAQ About Hua Medicine

Hua Medicine is a leading clinical-stage, innovative drug development company in China, focusing on novel therapies for the treatment of diabetes and CNS disorders. In order to meet the highest international standards, Hua Medince developed a powerful internal research quality supervision system...
Hua Medicine was founded in 2010.
Hua Medicine operates in Biotechnology, Health Care, Life Sciences and Pharmaceutical. Its work centres on Drug development, Clinical-stage company, Diabetes treatment and CNS disorder treatment.
Hua Medicine has approximately 56 employees.
Hua Medicine has completed 6 funding rounds, raising a total of $242.40M. The latest funding stage is Series E.
Top alternatives and competitors to Hua Medicine include Genprex, Inc., Creative BioTherapeutics LLC, BeBetter Med, CHORD Therapeutics, Apollomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hua Medicine and Genprex, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Hua Medicine, https://bouncewatch.com/company/hua-medicine, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes